The most important financial indicators for the company Sanacro Clinical Research Srl - Unique Identification Number 36157490:
sales in 2023 was
309.947
euro, registering a net profit of
28.899
euro and having an average number of
5
employees.
Firma isi desfasoara activitatea in domeniul Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 18.8%, from 261.707 euro in the year 2022, to 309.947 euro in 2023.
The Net Profit increased by 28.899 euro, from 0 euro in 2022, to 28.899 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Sanacro Clinical Research Srl - CUI 36157490
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
-
-
281
1.568
916
3.885
2.163
779
0
1.664
Current Assets
-
-
169
35.189
4.580
15.728
11.067
16.433
23.053
65.485
Inventories
-
-
0
0
0
0
0
0
0
0
Receivables
-
-
0
9.165
2.407
5.243
3.954
5.269
4.670
38.426
Cash
-
-
169
26.023
2.173
10.485
7.113
11.164
18.383
27.059
Shareholders Funds
-
-
-16.878
250
-35.583
-23.208
-31.853
-34.237
-37.401
-8.388
Social Capital
-
-
45
44
43
42
41
40
41
40
Debts
-
-
17.328
36.506
41.079
42.820
45.083
51.450
60.453
75.538
Income in Advance
-
-
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
65.485 euro in 2023 which includes Inventories of
0 euro, Receivables of
38.426 euro and cash availability of
27.059 euro.
The company's Equity was valued at
-8.388 euro, while total Liabilities amounted to
75.538 euro.
Equity increased by 28.899 euro, from -37.401 euro in 2022, to -8.388 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sanacro Clinical Research Srl